Recent studies in animals have demonstrated that growth hormone (GH) secretion is controlled by GH releasing factor (GHRF) and GH inhibiting factor (somatostatin). Somatostatin has not only been purified from the ovine hypothalamus, but also synthesized (Brazeau, Vale, Burgus, Ling, Butcher, Rivier & Guillemin, 1973) . It has been demonstrated recently that synthetic somatostatin suppresses the spontaneous secretion of GH and the increase in plasma GH induced by i.v. injection of pentobarbitone in the rat (Brazeau, Rivier, Vale & Guillemin, 1974) . We have previously reported that a single i.v. injection of isoprenaline or chlorpromazine causes a significant increase in plasma GH in the rat (Kato, Dupre & Beck, 1973) . In the present experiment, we examined the effect of synthetic somatostatin (kindly supplied by Dr N. Yanaihara) on the response of plasma GH to isoprenaline or chlorpromazine in rats.
Wistar strain male rats, weighing 180\p=n-\220 g, were housed in an air-conditioned room with a lighting scheme of 14 h light and 10 h darkness. Test substances were injected intravenously under urethane anaesthesia (150 mg/100 g body wt, i.p.) into rats fasted overnight. Jugular venous blood samples were taken before and 10, 20 and 40 min after the injection, and plasma GH was assayed by a specific radio¬ immunoassay as described previously (Kato et al. 1973) .
As shown in Table 1 , i.v. injection of isoprenaline (100/¿g/100 g) caused a rapid rise in plasma GH. The peak was observed 10 min after the injection. Concurrent i.v. administration of synthetic somatostatin (5/¿g/100 g) significantly suppressed the plasma GH response to isoprenaline. Significant increments in plasma GH were also caused by chlorpromazine (100 fig/100 (7) Isoprenaline ( We are grateful to Dr Noboru Yanaihara for supplies of synthetic somatostatin, and to the National Institute of Arthritis and Metabolic Diseases, NIH, for the material for rat GH radioimmunoassay.
